Global Neuromodulation Nm Reporting Unit — Net Sales
Boston Scientific Global Neuromodulation Nm Reporting Unit — Net Sales increased by 13.3% to $332.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 10.7%, from $300.00M to $332.00M. Over 4 years (FY 2021 to FY 2025), Global Neuromodulation Nm Reporting Unit — Net Sales shows an upward trend with a 7.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing market share or higher demand for the company's neuro-technology solutions, while a decrease may signal increased competition or market saturation in the neuromodulation space.
Detailed definition
This metric represents the total revenue generated from the sale of neuromodulation medical devices, which are used to t...
Peer comparison
Comparable to revenue reported by medical device peers specializing in neuro-stimulation, such as Medtronic or Abbott, within their respective neuromodulation or pain management business units.
bsx_segment_neuromodulation_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $247.00M | $221.00M | $243.00M | $209.00M | $239.00M | $221.00M | $248.00M | $234.00M | $244.00M | $229.00M | $269.00M | $256.00M | $282.00M | $268.00M | $300.00M | $271.00M | $303.00M | $293.00M | $332.00M |
| QoQ Change | — | -10.5% | +10.0% | -14.0% | +14.4% | -7.5% | +12.2% | -5.6% | +4.3% | -6.1% | +17.5% | -4.8% | +10.2% | -5.0% | +11.9% | -9.7% | +11.8% | -3.3% | +13.3% |
| YoY Change | — | — | — | — | -3.2% | +0.0% | +2.1% | +12.0% | +2.1% | +3.6% | +8.5% | +9.4% | +15.6% | +17.0% | +11.5% | +5.9% | +7.4% | +9.3% | +10.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's global neuromodulation nm reporting unit — net sales?
- Boston Scientific (BSX) reported global neuromodulation nm reporting unit — net sales of $332.00M in Q4 2025.
- How has Boston Scientific's global neuromodulation nm reporting unit — net sales changed year-over-year?
- Boston Scientific's global neuromodulation nm reporting unit — net sales increased by 10.7% year-over-year, from $300.00M to $332.00M.
- What is the long-term trend for Boston Scientific's global neuromodulation nm reporting unit — net sales?
- Over 4 years (2021 to 2025), Boston Scientific's global neuromodulation nm reporting unit — net sales has grown at a 7.2% compound annual growth rate (CAGR), from $909.00M to $1.20B.
- What does global neuromodulation nm reporting unit — net sales mean?
- Total revenue generated from the sale of medical devices designed to treat neurological conditions through electrical stimulation.